K-TAB Drug Patent Profile
✉ Email this page to a colleague
When do K-tab patents expire, and what generic alternatives are available?
K-tab is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in K-TAB is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for K-tab
A generic version of K-TAB was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for K-TAB?
- What are the global sales for K-TAB?
- What is Average Wholesale Price for K-TAB?
Summary for K-TAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 314 |
| Patent Applications: | 2,333 |
| What excipients (inactive ingredients) are in K-TAB? | K-TAB excipients list |
| DailyMed Link: | K-TAB at DailyMed |
Pharmacology for K-TAB
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for K-TAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | K-TAB | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 018279-002 | Aug 1, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | K-TAB | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 018279-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | K-TAB | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 018279-003 | Nov 25, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
